Donald Trump

The press conference was actually more interesting than the decision itself, which was widely expected and well telegraphed by the Federal Reserve, but the chairman insisted on two elements which are worthy of attention.

First rate rise in a year

Biotech sector not the only beneficiary

Harder to compete with US

Alex Wright, manager of the Fidelity Special Situations fund and Special Values investment trust, talks to editor Katrina Lloyd about whether an inflection point has been reached for value investing.

Portfolio 'stress tested' by Trump win

The election of Donald Trump as US President may mark a significant structural change in the post-crisis environment and a key turning point in markets.

As Donald Trump prepares to enter the White House, normally serious and intelligent people seem to have lost a sense of perspective, writes David Coombs, head of multi-asset investments at Rathbones.

US small caps to benefit from Trump victory